Sana Biotechnology to present updates at two major healthcare investor conferences in June 2026

Sana Biotechnology announced it will present business updates at the Jefferies Global Healthcare Conference on June 3 and the Goldman Sachs Global Healthcare Conference on June 9, 2026. These presentations will be webcast and accessible on Sana's investor relations website, with replays available for 30 days. The company focuses on engineered cell therapies aimed at treating diseases by repairing genes and replacing damaged cells. These events provide investors insight into Sana's progress and strategic direction in the biotech sector.